Dermata Therapeutics, Inc. (DRMA) NASDAQ

3.56

-0.045(-1.25%)

Updated at October 30 12:14PM

Currency In USD

Valuation

Market Cap206,550
Enterprise Value-2.96M
P/E Ratio-0.36
PEG Ratio-0.01
Price/Sales Ratio0
Price/Book Ratio0.66
Enterprise/Revenue0
Enterprise/EBITDA0.38

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0
Operating Margin0

Management Effectiveness

Return On Assets-1.56
Return On Equity-2.15

Income Statement

Revenue0
Revenue/Share0
Gross Profit0
EBITDA-12.29M
Net Income-12.29M
Diluted EPS-80.32

Balance Sheet

Total Cash6.48M
Total Cash/Share6.31
Total Debt0
Total Debt/Equity0
Current Ratio15.67
Book Value Per Share5.47

Price History

52-Week Change165.56
52-Week High23.7
52-Week Low3.58
Moving Average 50 Days4.96
Moving Average 200 Days7.99

Statistics

Average Volume136,494
Shares Outstanding681,557
% Held by Institutions38.16

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:10
Last Split DateAugust 01, 2025